| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.58 | 0.0006 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.56 | 0.003 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |